Kinases and ATPases produce adenosine diphosphate (ADP) as a common product, so an assay that detects ADP would provide a universal means for activity-based screening of enzymes in these families. Because it is known that most kinases accept ATPβS (sulfur on the β-phosphorous) as a substrate in place of adenosine triphosphate (ATP), the authors have developed a continuous assay using this substrate, with detection of the ADPβS product using dithio reagents. Such an assay is possible because dithio groups react selectively with ADPβS and not with ATPβS. Thiol detection was done using both Ellman's reagent (DTNB) and a recently developed fluorescent dithio reagent, DSSA. Therefore, the assay can be run in both absorbance and fluorescence detection modes. The assay was used to perform steady-state kinetic analyses of both hexokinase and myosin ATPase. It was also used to demonstrate the diastereoselectivity of hexokinase (R) and myosin ATPase (S) for the isomers of ATPβS, consistent with previous results. When run in fluorescence mode using a plate reader, an average Z´ value of 0.54 was obtained, suggesting the assay is appropriate for high-throughput screening. (Journal of Biomolecular
INTRODUCTION
K INASES CATALYZE THE TRANSFER of the γ phosphate of adenosine triphosphate (ATP) to a substrate. They can phosphorylate either "small molecules" or proteins, playing important roles in metabolism and regulation, respectively. A conserved aspartate in the active site acts as a general base, which deprotonates the substrate nucleophile that attacks the γ phosphate. 1 Small-molecule kinases phosphorylate nonprotein substrates such as glucose, pyruvate, and other metabolites. Typically, the coupling of phosphorylation to metabolic reactions transforms thermodynamically unfavorable reactions into highly exergonic reactions. Furthermore, phosphorylation acts as a trapping mechanism to retain metabolites within the cell. Most of the protein kinases are known to phosphorylate serine, threonine, tyrosine, or histidine residues on their substrates. Regulatory proteins and enzymes of various biochemical processes are either activated or deactivated by this phosphorylation. As such, protein kinases play crucial roles in transcription and translation initiation, apoptosis, replication, and many cell signaling cascades. Indeed, it is estimated that the vertebrate genome has more than 500 protein kinases performing these various functions 2 -so functional proteomic studies of kinases will likely identify many new drug targets, as well as produce a better understanding of the biochemistry behind cellular regulation.
With the sequencing of the human genome and the subsequent race to decode all the genes and their respective functions, the current interest in kinases will undoubtedly continue to grow. They have been linked to disorders such as inflammation and various cancers, making them attractive drug targets. There has already been a heavy investment by the pharmaceutical industry in drugs that target protein kinases, 3 spurred in part by the recent success of Gleevac, which targets Bcr-Abl kinase for the treatment of chronic myelogenous leukemia. 4 Now, more than 40 protein kinase inhibitors are in clinical trials, and many more are in preclinical studies.
This tremendous interest in kinases, both as drug targets and as targets of functional genomic/proteomic studies, means there is a need for more efficient and general high-throughput assays. Although displacement assays have been developed for kinases, 5, 6 activity-based assays are advantageous because they are more sensitive and direct, detecting changes in the biochemical activity associated with the biological function of the enzyme. At a minimum, it will always be important to complement a displacement-based assay with an activity-based assay. Although some widely used activity-based assays monitor phosphorylation of a peptide product using antibodies, 7-9 the most general activity-based assays are those that monitor the ATP to adenosine diphosphate (ADP) conversion, which is common to all kinases irrespective of which substrate it phosphorylates. There are many kinase assays available, including scintillation proximity assay (SPA)-based, fluorescence polarization (FP)-based, and fluorescence resonance energy transfer (FRET)-based assays. 10 One widely used assay is IMAP (Molecular Devices, Sunnyvale, CA), which is a fluorescence polarization assay where phosphorylated peptide is captured on a metal-derivatized nanoparticle. 11 Another commonly used assay strategy is to monitor production of a phosphorylated peptide in an FP assay, based on displacement of a fluorescently tagged phosphor-peptide from an antibody. 5 Such assays have been developed for both tyrosine and serine/threonine kinases. 12 A clever variation of this antibody displacement assay is the Transcreener™ assay (BellBrook Labs, Madison, WI), where fluorescently tagged ADP is displaced from antibodies raised against ADP. This assay has the potential to be a universal kinase assay, if adequate antibody selectivity for ADP over ATP can be achieved. But any antibody displacement assay is limited by the specificity of the antibody and may be prone to false positives from compounds that bind to the antibody. It is also possible to monitor ATP levels with a recently reported luminescent assay, 13, 14 which shows a decreasing signal as ATP is consumed. An assay that detects ADP production and gives an increasing fluorescence signal over time is currently not available, to our knowledge.
A more traditional kinase assay is a "coupled assay," which detects the production of ADP using a pyruvate kinase (PK)/ lactate dehydrogenase (LDH) assay. In this PK/LDH-coupled assay, ADP is phosphorylated by phosphoenol-pyruvate, catalyzed by PK. The pyruvate produced in this reaction is then reduced by nicotinamide adenine dinucleotide (NADH), catalyzed by LDH. One then monitors the disappearance of NADH, which has an extinction coefficient of ε 340 nm = 6.22 mM -1 cm -1 . Three major drawbacks of such an approach are apparent: 1) monitoring decreasing levels of NADH puts a rigid restriction on the dynamic range of the assay because too large an excess of NADH would give an absorbance outside the linear range, 2) the need to use coupling enzymes adds more reaction steps and therefore more work to validate the assay and verify hits, and 3) sensitivity is limited by the relatively low extinction coefficient of NADH. Herein we propose an alternative continuous assay that overcomes these limitations and can be used in either absorbance-or fluorescence-based detection modes. A survey of recent advances in enzyme screening shows a preference for chromogenic [15] [16] [17] assays using high molar absorptivity dyes, as well as fluorogenic [18] [19] [20] [21] assays. Most of these systems involve direct measurements or coupling to another chemical reaction, which simplifies the assay. Protein kinase assays based on fluorophores are being developed, 7, 22, 23 with many used in high-throughput screening (HTS) [24] [25] [26] applications. These assays are based on substrate displacement or substrate turnover (with direct or indirect detection). The latter is especially desirable because it provides signal amplification, permitting detection of enzyme at low concentrations.
Clearly, there is a need for an inexpensive, simple, sensitive, universal, and continuous activity-based assay that monitors an increasing signal. This assay should be amenable to HTS as well as functional proteomic studies to address the growing interest in kinases in drug discovery and basic cell biology. We therefore developed a general kinase assay based on the use of a well-tolerated ATP analogue, which yields a corresponding dithio-reactive ADP analogue during the kinase reaction. It has been demonstrated that there is differential reactivity of ATPβS and ADPβS 27 (thiol analogues of ATP and ADP, respectively) toward dithio groups. Furthermore, the presence of the sulfur atom introduces chirality on the β phosphorus. It had been demonstrated that kinases will prefer one diastereomer over the other (R/S) as a substrate. This stereochemical preference has not been extensively explored in protein kinases due to the difficulty of performing such studies for nonenzymologists, although the preference is well documented for a number of small-molecule kinases. 27 To demonstrate the ease of determining diastereotopic preference using the dithio-coupled assay, studies were done herein with representative enzymes in each diastereotopic class: those that prefer the R (hexokinase) or S (myosin) ATPβS diastereomers. In our studies, a dithio-bridged chromophore or fluorophore was used for detection. The chromogenic assay uses bis-dithionitrobenzoic acid (DTNB = Ellman's reagent) (1) , which is known to yield a yellow-colored chromophore (2) (β 412 nm = 13.5mM -1 cm -1 ) after cleavage. 28 The fluorogenic assay uses a recently developed dithio probe (DSSA), consisting of a cystamine linker and substituted with rhodamine and fluorescein (3). 29 This assay avoids the drawbacks associated with the traditional NADH-based coupled assay in the following ways: 1) the more
Et Et than 2-fold increase in molar extinction coefficient leads to an enhancement in sensitivity, 2) measurement of an increasing signal permits improvement in the dynamic range of the assay, and 3) there is no need for coupling to an enzyme reaction, which simplifies assay validation and hit verification procedures. The assay also provides structural information about the ATP binding site, in terms of diastereotopic preference for the R or S form of ATPβS, 4) if this information is desired. Finally, it can be performed using either absorbance-or fluorescence-based detection modes.
MATERIALS AND METHODS

Instrumentation and data processing
A Pharmacia fast protein liquid chromatography (FPLC) system, model LCC-501, was used for purifying ATPβS from the enzymatic synthesis mixture. An HP 8452A diode array spectrophotometer was used for analysis of column fractions, as well as for the UV/Vis-based kinase assay measurements. All spectroscopic measurements were taken at 25 °C in a 1-mL quartz cuvette. Time course measurements were at 4-sec intervals for at least 15 min. Steady-state kinetic data were fitted to the Michaelis-Menton or sigmoidal dose-response (IC 50 ) equations using the nonlinear least squares fitting algorithm in SigmaPlot 8.0. Fluorescence measurements were made on a BMG Polarstar plate reader at 25 °C, using 96-well plates. The reader was equipped with 485-nm excitation and 520-nm emission filters, both with a 10-nm bandpass. 31 P-NMR spectra were acquired on a 300 or 400 MHz ( 1 H) Varian nuclear magnetic resonance (NMR) spectrophotometers at room temperature and approximately pH 10, using H 3 PO 4 as reference.
Processing was done using the NUTS ® software package.
Materials
All salts, buffers, and enzymes, except where noted, were from Sigma-Aldrich (St. Louis, MO) and were of biochemical reagent grade. They were used without any further treatment or purification. Buffer pH was adjusted using either NaOH or HCl. Sephadex DEAE A25 ® resin and packed columns were from Amersham Biosciences (Piscataway, NJ). The resin was prepared for use according to the supplier's procedure. Polyethlyeneimine-cellulose thin-layer chromatography (TLC) plates were from VWR (West Chester, PA). Triethylamine was used to prepare triethylammonium bicarbonate buffer by bubbling carbon dioxide gas into a 2 M solution of triethylamine until the pH was between 7.6 and 7.8. The exact concentration of the buffer was determined by a back titration after addition of excess HCl. Enzymes were from the following organisms: LDH (rabbit muscle), PK (rabbit muscle), acetate kinase (Escherichia coli), myosin (pig), hexokinase (Saccharomyces cerevisiae), and glucose-6-phosphate dehydrogenase (G6PDH; Leuconostoc mesenteroides).
Synthesis of ATPβ β S: the R diastereomer 27
The following reaction mixture (total volume 7.0 mL) was prepared: 3.6 mM ADPβS, 7.2 mM MgCl 2 , 72 mM Tris-HCl (pH 8.0), 0.55 mM dithiothreitol, and 28.5 mM acetate phosphate. The 500 U of acetate kinase was added, and progress of the reaction was followed by spotting the mixture on PEIcellulose TLC plates at 30-min intervals, using pH 3.5 KH 2 PO 4 as the solvent. The reaction was almost complete after 6 h. ATPβS was purified from the mixture using a Sephadex DEAE A25 ® gravity or FPLC column, with triethylammonium bicarbonate as the mobile phase. A linear gradient of 0.05 M to 0.5 M buffer was used. The volatile buffer was removed with a rotary evaporator, and any remaining triethylamine was removed by performing at least 2 evaporations in methanol. The solid ATPβS (R) product (4) was recovered after freeze drying. The formation of ATPβS was confirmed by 31 P-NMR ( Fig. 1A) .
Synthesis of ATPβ β S: the S diastereomer 27
The following reaction mixture (total volume 17. 
as described above (Fig. 1B) . For both diastereomers, reasonably good chromatographic separation of ATPβS and ADPβS could be achieved during purification (Fig. 1C) .
pH stability of DTNB
pH variation studies of the stability of DTNB were done at 25.0 °C with 10 mM DTNB. The following 100 mM buffers were used for preparation of DTNB solutions at pHs close to their respective pK a values: phosphate (3.5), acetate (3.5), HEPES (7.0), Tris-HCl (8.2), and bicarbonate. Then, 10 mM solutions of DTNB were prepared in the given buffers and incubated for 10 min, and production of yellow color was monitored. pH 7 (HEPES) was chosen as the optimum pH for the coupled assay, both in terms of being optimum for enzyme activity and for DTNB stability.
Hexokinase kinetic studies
A G6PDH-coupled assay 30 was used for monitoring the specific activity of hexokinase, as well as for comparing the kinetic properties of ATPβS and the native substrate, ATP. For activity measurements, the incubation mixture contained the following: 10 mM glucose, 10 mM MgCl 2 , 12 mM NADP + , 11 U/mg G6PDH, 100 mM Tris-HCl (pH 8.4) buffer, and 2.5 mM ATP, at 25 °C. The reaction was initiated by addition of hexokinase, and production of NADPH was observed at 340 nm. For steady-state kinetic studies in which ATP was varied, the reaction mixture contained the following: 10 mM MgCl 2 , 12 mM NADP + , 11 U/mg G6PDH, 10 mM glucose, and 100 mM HEPES, and the ATP concentration was varied from 1 to 20 µM. Reaction was initiated by the addition of 50 U of hexokinase.
The incubation mixture for the DTNB-coupled assay using ATPβS (in which ATPβS was varied) contained the following: 10 mM MgCl 2 , 10 mM DTNB, 10 mM glucose, and 100 mM HEPES (pH 7.0), and the ATPβS concentration was varied from 1 to 20 µM. The reaction was initiated by the addition of 50 U of hexokinase. The incubation mixture for the DTNB-coupled assay in which hexokinase concentration was varied was as above, but with 0.20 mM ATPβS. Reactions were initiated by the addition of 3 to 35 U of hexokinase. These reactions were with the preferred ATPβS diastereomer (R), but control measurements were also made with the S diastereomer using the same reaction conditions. Inhibition studies were done with varied ADP.
Calcium-activated myosin ATPase kinetic studies 31-33
A PK/LDH-coupled assay was used for monitoring the specific activity of myosin, as well as for comparing the kinetic properties of the native substrate ATP, with ATPβS. For activity measurements with ATP, the incubation mixture contained the following: 20 µM NADH, 25 mM phosphoenolpyruvate, 10 U/mL LDH, 50 U/mL PK, 5 mM calcium, 10 mM MgCl 2 , and 1 mM ATP. The reaction was initiated by the addition of myosin. For kinetic studies in which the ATP was varied, the reaction mixture was as above, but with 4 to 409 µM Mg 2+ and 3 to 408 µM ATP. The reaction was initiated by the addition of 10 U of myosin.
The incubation mixture for the DTNB-coupled assay, in which ATPβS was varied, contained the following: 10 mM DTNB, 10 U/mL myosin, and 5 mM calcium. The Mg 2+ concentration was kept 1 mM above the ATPβS concentration. ATPβS was varied from 3.4 to 408 µM, and reactions were initiated by the addition of myosin. The incubation mixture for the DTNB-coupled assay, in which calcium-activated myosin was varied, contained the following: 10 mM DTNB, 32 µM ATPβS, and 5 mM calcium. The myosin concentration was varied from 3.4 to 408 µM, and reaction was initiated by the addition of myosin. These reactions were with the preferred ATPβS diastereomer (S), but control measurements were also made with the R diastereomer, using the same reaction conditions.
Additional control experiments
Calcium-activated myosin and hexokinase control assays were performed so as to gain insights into the relative reactivity of ADPβS, ATPβS, and protein thiols toward DTNB and hence their contributions, if any, to the observed UV absorption signal at 412 nm. The assay mixtures had the same composition as described above, except that only 1 of either ADPβS, ATPβS, or protein was present. The total assay time was no more than 10 min (Fig. 2) .
Fluorescence-coupled assay in plates
Production of ADPβS was also monitored using a fluorescencebased version of the dithio-coupled assay. In place of DTNB, a fluorescent dithio reagent was used (DSSA: 3), which contained cystamine labeled on its amino groups using fluorescein isothiocyanide and rhodamine sulphonyl chloride. 29 The hexokinase assay mixture contained 10 mM MgCl 2 , 10 mM glucose, 10 µM DSSA (3), 100 mM (pH 7.0) HEPES buffer, and 1 to 5 U/µL hexokinase activity, and ATPβS varied from 10 to 120 µM. Control reactions used for Z′ measurements were the same but did not have hexokinase present. Fluorescence measurements were made using a BMG Polarstar fluorimeter equipped with a 96-well plate reader. Excitation was with 10 flashes per measurement, 0.1-sec position delay, and 5 mixing cycles before protein injection to initiate the assay. Initial velocities were measured as fluorescence increased but after a brief decrease in fluorescence, before the steady-state was reached.
RESULTS AND DISCUSSION
All kinases and ATPases produce ADP, so an assay that detects ADP would be a universal assay of potential use in enzymology as well as high-throughput screening. To this end, we have developed a chemically coupled assay where ATPβS is used as a substrate in place of ATP, and the ADPβS that is produced is selectively detected. Such detection is possible because ADPβS reacts with dithio groups (Fig. 3A) , whereas ATPβS does not. Therefore, reaction can be followed using dithio reagents such as DTNB (1), for a chromogenic assay, or a fluorescent dithio reagent such as DSSA (3), for a fluorogenic assay. It is important to note that the dithio reagent is not likely to oxidize the protein significantly in the timeframe of the assay, relative to the reaction being monitored. This is because the protein being assayed is typically present in the low nanomolar range, whereas the ADPβS is being produced at concentrations that are several orders of magnitude higher-and conditions are always adjusted such that reaction between ADPβS and dithio is at a measurable rate in the timeframe of the assay.
The primary reagent required for the dithio-coupled assay is ATPβS, which is not commercially available. But both diastereomers of ATPβS (S and R) can be synthesized enzymatically by established methods. 27 31 P-NMR chemical shifts for the enzymatically synthesized ATPβS products are in agreement with the previously reported values 34 of -11.4 ppm (doublet), -5.8 ppm (doublet), and 30 ppm (triplet) for the α, γ, and β phosphorus atoms, respectively (Fig. 1) . Purification of the enzymatically synthesized ATPβS on a DEAE column shows reasonable separation from ADPβS, which is important because contaminating ADPβS would lead to a high background reduction of the dithio probe and may also act as a product inhibitor in the assay. The former is demonstrated in Figure 2 , where it can be seen that if residual ADPβS is present, there is a burst in signal for both the hexokinase and the myosin assays. If contaminating ADPβS is present, both problems can be minimized by first consuming the ADPβS by preincubating the reaction mixture before adding kinase. There is little background rate in the absence of ATPβS or after residual ADPβS is consumed (Fig. 2) . Residual ADPβS can also be removed by passing over a thiol affinity resin, such as Activated Thiol Sepharose 4B (GE Healthcare, Chalfont St. Giles, UK). But ADPβS and other contaminants can usually be avoided at the outset by taking more conservative cuts of fractions during purification (Fig. 1C) and by avoiding prolonged sample concentration via rotary evaporation.
It should be noted that the polyphosphate/phosphorothioate of both ATPβS and ADPβS are quite stable at high pH, showing no detectable changes in 31 P-NMR spectra after 3 weeks at pH 11 (carbonate buffer). Furthermore, ADPβS shows only 3% hydrolysis after 3 days at pH 7.4 (HEPES) but nearly complete hydrolysis at pH 3.4 (glycine) in < 1 h. All stability studies were at 4 °C and based on changes in 31 P NMR spectra, so they reflect only the stability of the polyphosphate/phosphorothioate. In terms of stability issues during ATPβS preparation, concentration of the enzymatic synthesis reaction mixture using a rotary evaporator often led to some decomposition of ATPβS, so lyophilization is preferred. A potential problem is that the enzymatic syntheses have previously been reported to be less than 100% diastereoselective, leading to minor contamination with the undesired diastereomer. 35 But this was not apparent from the 31 P-NMR spectra (Fig. 1) , perhaps because solutions were too dilute, such that only the major diastereomer (> 80%) could be detected. In any case, diastereotopic purity may not be required for routine assays.
The dithio-coupled assay can be implemented for any kinase or ATPase, simply by substituting ATP with ATPβS and adding a dithio coupling reagent such as DTNB or the DSSA probe (Fig. 3A) . Although kinases and ATPases will prefer either the R or S diastereomer of ATPβS, a mixture of diastereomers can be used, and only 1 will be used by the enzyme. Otherwise, it will be necessary to try both diastereomers to determine the preference for the kinase being studied. Steady-state kinetic rates for the kinase or ATPase reaction are measured from progress curves, monitoring changes in absorbance for DTNB ( Fig. 3B) or fluorescence for the DSSA probe (see below). Initial velocities are extracted from the early part of the progress curves. As in any coupled assay, it is important to make sure that the reaction rate is proportional to enzyme concentration and not limited by rate of reaction in the coupling step (ADPβS reaction with DTNB). This was demonstrated with a validation curve for the myosin ATPase reaction (Fig. 4) . Once an enzyme concentration is chosen from the linear part of the validation curve, a full steady-state kinetic analysis can be performed, as shown in Figure 5B for calcium-activated myosin ATPase. Therefore, steady-state kinetic analyses can be pursued using the dithio-coupled assay (Fig. 5B) as an alternative to the widely used PK/LDH-coupled assay (Fig. 5A) . Thorough steady-state analysis is required to establish the mechanism of inhibition (as competitive, noncompetitive, or uncompetitive) for inhibitors identified from screening campaigns. The preference of myosin for the S diastereomer of ATPβS 27 could be clearly demonstrated, although this could also be done more simply in a higher throughput screen by simply comparing progress curves for ATPβS (R) and ATPβS (S) diastereomers.
Interestingly, the validation curve for the DTNB-coupled assay with hexokinase indicates that at higher concentrations, the reaction rate is no longer proportional to enzyme concentration (Fig. 6) . This emphasizes the importance of doing validation curves to choose an appropriate enzyme concentration, as is routine practice for any coupled assay. At an appropriate lower enzyme concentration, the DTNB-coupled assay could be used for a steady-state analysis of hexokinase as well (Fig. 7) . In this case, the preference of hexokinase for the R diastereomer of ATPβS could also be clearly demonstrated. For both hexokinase and myosin, there was a modest decrease in K m for ATPβS relative to ATP ( Table 1) . This is actually an advantage in the assay because it means that less ATPβS is required, with the optimal cofactor concentration in the assay determined relative to its K m . This reduced K m value would have no effect on the measured K i (or IC 50 ) for a kinase inhibitor because K i is not a function of K m for ATPβS but rather of the [cofactor]/K m ratio chosen for the assay. Also, it should be noted that this assay will detect any kinase inhibitor, irrespective of whether it binds in the ATP site, because it monitors inhibition of the reaction rate, not simply competitive displacement.
Sensitivity of the assay is greater than that of NADHcoupled assays due to the higher extinction coefficient of DTNB. As such, it should be possible to detect ADPβS concentrations as low as 0.1 µM and as high as 100 µM in a 1-cm path-length cuvette. One should therefore adjust enzyme concentration so that the first 5% to 10% of the reaction is being read in the desired timeframe (e.g., 10-60 min) within this dynamic range. Unlike assays that detect decreasing fluorescent or visible signal (e.g., NADH-coupled assays), one can increase the detectable probe's concentration in order to push the equilibrium for the reaction-to produce more linear A potential concern with this assay is that the dithio probe may be reduced by added protein reductants, such as DTT (dithiothreitol), TCEP (Tris(2-carboxyethyl)phosphine), or β-ME (β-mercaptoethanol). For proteins that require thiol reductants for activity, especially when detecting with DTNB (DSSA does not easily oxidize proteins), it is best to maintain the enzyme stock solution in 1 mM β-ME, then to dilute it into an assay mixture that has no reductant (a 1:40 dilution would produce only 25 µM β-ME in the assay). For the brief period of the assay, there is usually little oxidation of protein thiols. This approach has been taken in an inhibition assay with hexokinase ( Fig. 8) , where a hexokinase stock was maintained in 1 mM β-ME and then diluted into an assay mixture that had no thiol reductant. Hexokinase has 5 cysteines and no disulfide bonds. The IC 50 obtained for the ADP inhibitor of hexokinase was the same with β-ME present (Log[IC 50 ] = 2.8 ± 0.3) as it was without β-ME present (Log[IC 50 ] = 3.0 ± 0.3), and it was in reasonable agreement with the previously reported Log[K i ] of 3.2. 36 The concern over protein oxidation by thiol detection probe is lessened if DSSA is used due to its low reduction potential (E o ′ = −0.6 V). 29 The DSSA probe is also not easily reduced by protein thiol reductants such as β-ME. Of the commonly used protein reductants, β-ME reacts the slowest with the fluorescent probe ( Fig. 9) , so it is the preferred reagent to use.
Because this dithio-coupled assay may be useful for the HTS of kinases and ATPases, a fluorescent version of the assay using the DSSA probe is being developed as well. As just discussed, this version of the assay is advantageous because DSSA is less likely to cause any oxidation of protein thiols (and has decreased reactivity with β-ME). The fluorescent form of the assay is similar to that described above, but DTNB is replaced with a fluorescent dithio probe such as DSSA (3). The fluorescent probe is reduced by ADPβS in the same manner as DTNB, but it can be present at a much lower concentration. It is typically present at a 1 to 10 µM concentration, whereas ADPβS is present in a much larger excess. Because of the low redox potential of the DSSA probe (E o ′ = -0.60 V), 29 significant reduction is observed only at high concentrations of thiol, and the rate of fluorescence change remains linearly dependant on thiol concentration.
The fluorescence assay was validated in a 96-well plate format by comparing initial velocities in the presence or absence of hexokinase and in triplicate, so that Z′ values 37 could be calculated according to the following equation:
The assay was performed at ATPβS concentrations of 10, 20, 30, 40, 60, 90, and 120 µM (Fig. 10) , and the average Z′ value was 0.54. 
CONCLUSIONS
The general kinase and ATPase assay presented herein is a simple, reliable, and sensitive way of measuring enzyme activity, using ATPβS as substrate. It was demonstrated that ADPβS reacts very rapidly with DTNB compared to ATPβS and protein, the other sources of free thiols in the assay. Although the dithiocoupled assay needs to be tested on other kinases, it should be a universal assay because it relies on detection of ADPβS, a broadly tolerated analogue of ADP, the product common to all kinase and ATPase reactions. The results from the chromogenic assay using DTNB have clearly shown that for hexokinase and myosin, this assay is effective. If desired, the diastereoselectivity of an enzyme toward the ATPβS diastereomers can also be determined to classify kinase active sites. Finally, a fluorescence version of this assay is robust enough for HTS of kinases because the Z′ value of 0.54 is above the recommended value of 0.5 for HTS assays.
